Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer

Matthew D. Hellmann(Memorial Sloan Kettering Cancer Center), Margaret K. Callahan(Memorial Sloan Kettering Cancer Center), Mark M. Awad(Dana-Farber Cancer Institute), Emiliano Calvo(Hospital Universitario HM Sanchinarro), Paolo A. Ascierto(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Akin Atmaca(Goethe University Frankfurt), Naiyer A. Rizvi(Columbia University Irving Medical Center), Fred R. Hirsch(University of Colorado Anschutz Medical Campus), Giovanni Selvaggi(Bristol-Myers Squibb (United States)), Joseph D. Szustakowski(Bristol-Myers Squibb (United States)), Ariella Sasson(Bristol-Myers Squibb (United States)), Ryan Golhar(Bristol-Myers Squibb (United States)), Patrik Vitazka(Bristol-Myers Squibb (United States)), Chang Han(Bristol-Myers Squibb (United States)), William J. Geese(Bristol-Myers Squibb (United States)), Scott Antonia(Moffitt Cancer Center)
Cancer Cell
May 1, 2018
10.1016/j.ccell.2018.04.001
Cited by 893Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis